Skip to content

PolitiKit

Stephen Sampson's lobbying: the clients they represent and every meeting they've reported since November 2021.

← Lobbying

Consultant lobbyist

Stephen Sampson

Global Public Affairs

Former public offices

  • Legislative Assistant, Office of the Government House Leader, Privy Council Office (PCO) (2004–2006)
  • Special Assistant (Policy), Office of the Minister of Transport, Transport Canada (2003–2004)
  • Executive Assistant, Office of M.P. for Hamilton East - Stoney Creek, House of Commons (2001–2003)
  • Legislative Assistant, Office of M.P. for Hamilton Mountain, House of Commons (2000–2001)
Meetings this Parliament
4
Since Nov 2021
15
Active registrations
8

Reported meetings

  • API Labs Inc.
    • Jibril Hussein · Senior Policy Advisor, Health Canada (HC)
    • Gracia Katahwa · Director of Policy, Health Canada (HC)
    The submission of an application for a ministerial exemption under s. 56 of the Controlled Drugs and Substances Act.

    Official report

  • API Labs Inc.
    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    The submission of an application for a ministerial exemption under s. 56 of the Controlled Drugs and Substances Act.

    Official report

  • API Labs Inc.
    • Scott Tannas · Senator, Senate of Canada
    • Todd Lewis · Senator, Senate of Canada
    The submission of an application for a ministerial exemption under s. 56 of the Controlled Drugs and Substances Act.

    Official report

  • API Labs Inc.
    • Guy Gallant · Chief of Staff, Agriculture and Agri-Food Canada (AAFC)
    The submission of an application for a ministerial exemption under s. 56 of the Controlled Drugs and Substances Act.

    Official report

  • API Labs Inc.
    • Jennifer Saxe · Associate Assistant Deputy Minister, Health Canada (HC)
    The submission of an application for a ministerial exemption under s. 56 of the Controlled Drugs and Substances Act.

    Official report

  • JN Nova Pharma Inc.
    • Laurel Chester · Senior Advisor, Innovation, Science and Economic Development Canada (ISED)
    • Simran Arulraj · Special Assistant, Innovation, Science and Economic Development Canada (ISED)

    HealthIndustryIntellectual PropertyResearch and DevelopmentScience and Technology

    Official report

  • JN Nova Pharma Inc.
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)

    HealthIndustryIntellectual PropertyResearch and DevelopmentScience and Technology

    Official report

  • JN Nova Pharma Inc.
    • Marie-France Lalonde · Member of Parliament
    • Mahdi Ellorhaoui · Member's Assistant, House of Commons

    HealthIndustryIntellectual PropertyResearch and DevelopmentScience and Technology

    Official report

  • API Labs Inc.
    • Eric Costen · Associate Deputy Minister, Health Canada (HC)
    • Kendal Weber · Assistant Deputy Minister, Health Canada (HC)

    HealthIndustry

    Official report

  • API Labs Inc.
    • Ophelia John · Policy Advisor, Health Canada (HC)
    • Eshan Naik · Director of Policy, Health Canada (HC)

    HealthIndustry

    Official report

  • API Labs Inc.
    • Shaili Patel · Director of Policy, Health Canada (HC)

    HealthIndustry

    Official report

  • API Labs Inc.
    • Shaili Patel · Director of Policy, Health Canada (HC)

    HealthIndustry

    Official report

  • Exactis Innovation
    • Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)
    • Victor Kandasamy · Policy Advisor (Quebec), Health Canada (HC)

    HealthResearch and DevelopmentScience and Technology

    Official report

  • API Labs Inc.
    • Elliott Lockington · Chief of Staff to the Minister, Finance Canada (FIN)
    • Justin Mohr · Policy Advisor, Finance Canada (FIN)

    HealthIndustry

    Official report

  • API Labs Inc.
    • Shaili Patel · Director Of Policy, Health Canada (HC)

    HealthIndustry

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.